We are very excited that CJC is now officially recognized by the Thomson Reuters and publications in CJC since 2012 will be tracked for citation toward its calculation of impact factor. On this high level, CJC will continue to embrace critical thoughts, insightful studies, novel technologies, and meaningful clinical experiences.
We would like to thank the evaluators at the Thomson Reuters for recognizing the value of CJC. We want to thank all the editorial board members for their guidance and all the editorial staff for their tireless work. We especially want to thank all our authors for contributing
